Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients

Surgery for Obesity and Related Diseases

Volumn 12, Issue 4, 2016, Pages 822-827

  Scopinaro, Nicola ^a   Camerini, Giovanni ^a   Papadia, Francesco ^a   Andraghetti, Gabriella ^a   Cordera, Renzo ^a   Adami, Gian Franco ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute insulin response; Bariatric surgery; Biliopancreatic diversion; Insulinogenic index; Obesity degree; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; BODY MASS; CELLULAR SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; INSULIN TREATMENT; INSULINOGENIC INDEX; MALE; METABOLIC PARAMETERS; MIDDLE AGED; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; AGED; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; METABOLISM; OBESITY; PHYSIOLOGY; POSTOPERATIVE CARE; PROCEDURES; PROSPECTIVE STUDY; SECRETION (PROCESS); WEIGHT REDUCTION;

ADULT; AGED; BILIOPANCREATIC DIVERSION; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; OBESITY; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84959285375     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2015.12.011     Document Type: Article

References (30)

1. N. Scopinaro, E. Gianetta, D. Friedman, G.F. Adami, E. Traverso, and V. Bachi Evolution of biliopancreatic bypass Clin Nutr 5 suppl 1986 137 146
2. N. Scopinaro, G.F. Adami, U.M. Marinari, and et al. Biliopancreatic diversion World J Surg 22 9 1998 936 946
3. G. Mingrone, S. Panunzi, A. De Gaetano, and et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial Lancet 386 9997 2015 964 973
4. H. Buchwald, R. Estok, K. Fahrbach, and et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am J Med 122 3 2009 248 256
5. B.P. Müller-Stich, J.D. Senft, R. Warschkow, and et al. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis Ann Surg 261 3 2015 421 429
6. G. Ribaric, J.N. Buchwald, and T.W. McGlennon Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis Obes Surg 24 3 2014 437 455
7. N. Scopinaro, G.M. Marinari, G.B. Camerini, F.S. Papadia, and G.F. Adami Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study Diabetes Care 28 10 2005 2406 2411
8. N. Scopinaro, F. Papadia, G. Camerini, G. Marinari, D. Civalleri, and G.F. Adami A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations Obes Surg 18 8 2008 1035 1038
9. G.F. Adami, R. Cordera, G. Camerini, G.M. Marinari, and N. Scopinaro Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion J Surg Res 113 2 2003 217 221
10. G.F. Adami, R. Cordera, G. Camerini, G.M. Marinari, and N. Scopinaro Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity Int J Obes Relat Metab Disord 28 5 2004 671 673
11. L. Briatore, B. Salani, G. Andraghetti, and et al. Restoration of acute insulin response in T2 DM subjects 1 month after biliopancreatic diversion Obesity 16 1 2008 77 81
12. E.V. Polyzogopoulou, F. Kalfarentzos, A.G. Vagenakis, and T.K. Alexandrides Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery Diabetes 52 5 2003 1098 1103
13. C. Guidone, M. Manco, E. Valera-Mora, and et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery Diabetes 55 7 2006 2025 2031
14. M.E. Valera-Mora, B. Simeoni, L. Gagliardi, and et al. Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery Am J Clin Nutr 81 6 2005 1292 1297
15. A.V. Greco, G. Mingrone, A. Giancaterini, and et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion Diabetes 51 1 2002 144 151
16. A Jiménez, R Casamitjana, J Viaplana-Masclans, A Lacy, and J Vidal GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery Diabetes Care 36 7 2011 2062 2069
17. R.T. Patel, A.P. Shukla, S.M. Ahn, M. Moreira, and F. Rubino Surgical control of obesity and diabetes: the role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis Obesity (Silver Spring) 22 1 2014 159 169
18. 2): a prospective controlled study Obes Surg 21 7 2011 880 888
19. N. Scopinaro, G.F. Adami, F.S. Papadia, and et al. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 Ann Surg 253 4 2011 699 703
20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2000) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (Position Statement) Diabetes Care 23 Suppl 1 2000 S4 19
21. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 7 1985 412 419
22. R.L. Hanson, R.E. Pratley, C. Bogardus, and et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies Am J Epidemiol 151 2 2000 15 190 198
23. A. Tura, A. Kautzky-Willer, and G. Pacini Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT Diabetes Res Clin Pract 72 3 2006 298 301
24. B.L. Wajchenberg Beta-cell failure in diabetes and preservation by clinical treatment Endocr Rev 28 2 2007 187 218
25. D. Porte Jr, and S.E. Kahn beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms Diabetes 50 Suppl 1 2001 S160 S163
26. R.A. Ritzel, A.E. Butler, R.A. Rizza, J.D. Veldhuis, and P.C. Butler Relationship between beta- cell mass and fasting blood glucose concentration in humans Diabetes Care 29 3 2006 717 718
27. Y. Saisho, A.E. Butler, E. Manesso, D. Elashoff, R.A. Rizza, and P.C. Butler β-cell mass and turnover in humans: effects of obesity and aging Diabetes Care 36 1 2013 111 117
28. A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, and P.C. Butler Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 1 2003 102 110
29. P.A. Halban, K.S. Polonsky, D.W. Bowden, and et al. β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment Diabetes Care 37 6 2014 1751 1758
30. M. Fried, V. Yumuk, J.M. Oppert, and et al. International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC); European Association for the Study of Obesity (EASO); European Association for the Study of Obesity, Obesity Management Task Force (EASO OMTF). Interdisciplinary European guidelines on metabolic and bariatric surgery Obes Surg 24 1 2014 42 55